Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors-Reference-Cited by-同舟云学术

Resistance to Human Immunodeficiency Virus Type 1 Protease Inhibitors

Published:1998-11 Issue:11 Volume:42 Page:2775-2783
ISSN:0066-4804
Container-title:Antimicrobial Agents and Chemotherapy
language:en
Short-container-title:Antimicrob Agents Chemother

Author:

Boden Daniel¹,Markowitz Martin¹

Affiliation:

1. Aaron Diamond AIDS Research Center, New York, New York

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology

Link

https://journals.asm.org/doi/pdf/10.1128/AAC.42.11.2775

Reference97 articles.

1. Design of enzyme inhibitors using iterative protein crystallographic analysis.;Appelt K. R.;J. Med. Chem.,1991

2. Cameron D. W. A. J. Japour Y. Xu A. Hsu C. Cohen C. Farthing S. Follansbee M. Markowitz J. Mellors D. Poretz J. B. Angel D. Ho D. McMahon V. Devanarayan R. Rode M. Salgo D. Kempf R. Granneman J. M. Leonard and E. Sun. Ritonavir and saquinavir combination therapy for the treatment of HIV infection. Submitted for publication.

3. Three-dimensional structure of a mutant HIV-1 protease displaying cross-resistance to all protease inhibitors in clinical trials.;Chen Z.;J. Biol. Chem.,1995

4. In vitro combination of PNU-140690, a human immunodeficiency virus type 1 protease inhibitor, with ritonavir against ritonavir-sensitive and -resistant clinical isolates

5. HIV population in vivo: implications for genetic variation, pathogenesis, and therapy.;Coffin J. M.;Science,1995

Cited by 178 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimization of HIV Sequencing Method Using Vela Sentosa Library on Miseq Ilumina Platform;Genes;2024-02-19

2. Non-active site mutations in the HIV protease: Diminished drug binding affinity is achieved through modulating the hydrophobic sliding mechanism;International Journal of Biological Macromolecules;2022-09

3. Nirmatrelvir–remdesivir association for non-hospitalized adults with COVID-19, point of view;Inflammopharmacology;2022-08-18

4. Potential Resistance of SARS-CoV-2 Main Protease (Mpro) against Protease Inhibitors: Lessons Learned from HIV-1 Protease;International Journal of Molecular Sciences;2022-03-23

5. Combining Molecular Dynamic Information and an Aspherical-Atom Data Bank in the Evaluation of the Electrostatic Interaction Energy in Multimeric Protein-Ligand Complex: A Case Study for HIV-1 Protease;Molecules;2021-06-24